Overview

Long Term Open Follow-up With H376/95 vs. Warfarin

Status:
Terminated
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate tolerability of long-term treatment with ximelagatran compared to standard treatment with warfarin.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Warfarin
Ximelagatran